![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 17, 14474-14481, April 27, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the L-plastin (LPL) is a leukocyte actin binding
protein previously implicated in the activation of the integrin
L-plastin Peptide Activation of
v
3-mediated Adhesion Requires Integrin
Conformational Change and Actin Filament Disassembly*
,
Program in Molecular Cell Biology, Division
of Biology and Biomedical Sciences, Washington University School of
Medicine, St. Louis, Missouri 63110 and the § Program in
Host-Pathogen Interactions, University of California, San Francisco,
San Francisco, California 94143
M
2 on polymorphonuclear neutrophils. To determine the role for LPL in integrin activation, K562
cell adhesion to vitronectin via
v
3, a
well-studied model for activable integrins, was examined. Cell permeant
versions of peptides based on the N-terminal sequence of LPL and the
LPL headpiece domain both activated
v
3-mediated adhesion. In contrast to
adhesion induced by treatment with phorbol 12-myristate 13-acetate (PMA), LPL peptide-activated adhesion was independent of
integrin
3 cytoplasmic domain tyrosines and was not
inhibited by cytochalasin D. Also in contrast to PMA, LPL peptides
synergized with RGD ligand or Mn2+ for generation of a
conformational change in
v
3 associated with the high affinity state of the integrin, as determined by binding
of a ligand-induced binding site antibody. Although LPL and ligand
showed synergy for ligand-induced binding site expression when actin
depolymerization was inhibited by jasplakinolide, LPL peptide-induced adhesion was inhibited. Thus, both actin
depolymerization and ligand-induced integrin conformational change are
required for LPL peptide-induced adhesion. We hypothesize that the
critical steps of increased integrin diffusion and affinity enhancement may be linked via modulation of the function of the actin binding protein L-plastin.
*
This work was supported by Grant AI35811 from the National
Institutes of Health (to E. J. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
A. Hryniewicz-Jankowska, P. K. Choudhary, and S. R. Goodman Variation in the Monocyte Proteome Experimental Biology and Medicine, July 1, 2007; 232(7): 967 - 976. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Iyer, R. S. Agrawal, C. R. Thompson, S. Thompson, J. A. Barton, and D. J. Kusner Phospholipase D1 Regulates Phagocyte Adhesion J. Immunol., March 15, 2006; 176(6): 3686 - 3696. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Brittain, J. Han, K. I. Ataga, E. P. Orringer, and L. V. Parise Mechanism of CD47-induced {alpha}4{beta}1 Integrin Activation and Adhesion in Sickle Reticulocytes J. Biol. Chem., October 8, 2004; 279(41): 42393 - 42402. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Iyer, J. A. Barton, S. Bourgoin{section}, and D. J. Kusner Phospholipases D1 and D2 Coordinately Regulate Macrophage Phagocytosis J. Immunol., August 15, 2004; 173(4): 2615 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pilch, R. Habermann, and B. Felding-Habermann Unique Ability of Integrin alpha vbeta 3 to Support Tumor Cell Arrest under Dynamic Flow Conditions J. Biol. Chem., June 7, 2002; 277(24): 21930 - 21938. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sahali, A. Pawlak, A. Valanciute, P. Grimbert, P. Lang, P. Remy, A. Bensman, and G. Guellen A Novel Approach to Investigation of the Pathogenesis of Active Minimal-Change Nephrotic Syndrome Using Subtracted cDNA Library Screening J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1238 - 1247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |